Obesity and Diabetes
Research from Center for Endocrine and Metabolic Diseases provides new data about obesity and diabetes
Published in Obesity and Diabetes Week, September 24th, 2007
Scientists discuss in "Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism" new findings in obesity and diabetes. According to a study from Bochum, Germany, "Insulin resistance and obesity are common features of the polycystic ovary syndrome (PCOS). Retinol-binding protein 4 (RBP4), a new fat-derived adipokine, has been described to be elevated in obesity and type 2 diabetes."
"The aim of the present study was to investigate whether serum RBP4 levels are correlated with metabolic parameters, indices of insulin resistance, and endocrine variables in German PCOS women. We assessed the correlation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity and Diabetes
Drug could improve pregnancy outcomes in wider range of women with insulin resistance - Obesity and Diabetes
UT Southwestern's obesity research receives $22 million NIH Roadmap grant - Obesity
With an Aggressive Generics Strategy and an Excellence Plan to Reduce Readmission/Complication Rates for Bariatric Surgery, Blue Cross and Blue Shield of North Carolina is Serious About Cutting Costs - Gene Therapy
Research from Nanjing Medical University has provided new data on gene therapy - Obesity and Diabetes
Research conducted at Children's Hospital has updated our knowledge about obesity and diabetes in children - Obesity and Diabetes
Research from Niigata University yields new data on obesity and diabetes in children - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
